COMPARATIVE ANALYSIS OF SOFTWARE FOR PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING: SIMULATION, OPTIMIZATION, AND SENSITIVITY ANALYSIS

Historically, a number of different software packages running on a variety of hardware platforms have been used for model simulation. SimuSolv found wide use because of its broad capabilities, including optimization, statistical analysis, and formalized sensitivity analysis as well as the capacity to incorporate user-supplied subroutines. However, in the early 1990s, SimuSolv development ceased and a final version was released in 1993. Thus SimuSolv will not be developed for newer platforms and operating systems. In this article, we compare and contrast the use of SimuSolv and Matlab (The MathWorks, Natick, MA) for physiologically based pharmacokinetic (PBPK) model implementation with respect to parameter estimation (optimization) and sensitivity analysis using a PBPK model for trichloroethylene (TCE). In both packages, it is possible to code PBPK models, run simulations, estimate parameters, and do sensitivity analysis.The key difference is the additional programming required in Matlab. Since Matlab does not have built-in estimation and sensitivity routines, it was necessary to write them for the Matlab TCE model. Additionally, Matlab handles flow control differently from SimuSolv, so the model code is written in a different order than for SimuSolv. In spite of the additional coding requirements, Matlab is a well-supported and mathematically oriented simulation software package that is clearly suitable for application to PBPK modeling. All of the modeling tasks done in SimuSolv could also be done readily in Matlab. Most of the comparisons made to SimuSolv also carry over to ACSL-Tox, however ACSL-Tox calculates some sensitivity coefficients very differently from the way they are defined in SimuSolv. Future development of an interpreter for Matlab would make modeling, sensitivity analysis, and parameter estimation less programming-intensive.

[1]  M. Evans,et al.  A Versatile Gas Uptake Inhalation System Used in Pharmacokinetic and Metabolic Studies of Volatile Organic Compounds , 1995 .

[2]  M E Andersen,et al.  Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. , 1989, Toxicology and applied pharmacology.

[3]  S. Haddad,et al.  A Simple Index for Representing the Discrepancy between Simulations of Physiological Pharmacokinetic Models and Experimental Data , 1995, Toxicology and industrial health.

[4]  J E Simmons,et al.  Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats. , 1994, Toxicology and applied pharmacology.

[5]  H J Clewell,et al.  Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[6]  M. Andersen,et al.  Sensitivity Analysis and the Design of Gas Uptake Inhalation Studies , 1995 .

[7]  R. Melnick,et al.  Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. , 1993, Carcinogenesis.

[8]  S. Borghoff,et al.  A physiological model for tert-amyl methyl ether and tert-amyl alcohol: hypothesis testing of model structures. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  H J Clewell,et al.  Applying simulation modeling to problems in toxicology and risk assessment--a short perspective. , 1995, Toxicology and applied pharmacology.